Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
In patients with Duchenne Muscular Dystrophy who have an exon 51 mutation, do you treat with both prednisone and Eteplirsen?
What are common side effects to look out for with Eteplirsen?
Related Questions
How do you track objective clinical response to treatment in CIDP?
How do you counsel patients who wish to travel to high altitudes with myasthenia gravis?
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
How do you treat nocturnal leg cramps?
What is your approach to a child with toe walking with a reassuring exam but a family history of difficulty walking?
How do you utilize corticosteroids in the management of CIDP?
Is measuring total IgG levels during acute myasthenia gravis exacerbations helpful for monitoring treatment or guiding the number of plasma exchange procedures?
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
How frequently do you re-evaluate AChR and MuSK antibodies in patients with clinical and electrodiagnostic evidence of seronegative myasthenia gravis?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?